不眠症のためのデジタル療法:総括レビューとメタメタ分析
PubMedで要約を見る
まとめ
この要約は機械生成です。デジタルセラピーは 特にセラピストの指導で 睡眠不足を大幅に改善します これらのデジタル・ヘルス・ソリューションは 睡眠障害を効果的に管理するための 有望で根拠のあるアプローチを提供します
科学分野
- デジタル・ヘルス
- 睡眠医学
- 証拠 に 基づく 実践
背景
- 不眠症は公衆衛生上の大きな問題であり, 治療の選択肢が容易かつ有効である必要があります.
- デジタル療法 (DTx) は 不眠症の管理に 有望な手段として 登場しています
- 不眠症に対するDTxの有効性を理解するには,既存の証拠の包括的なレビューが不可欠です.
研究 の 目的
- 睡眠障害の治療における デジタル治療の効果を 体系的に評価する.
- 不眠症の重度と睡眠のパラメータに対するDTxの影響を評価する.
- 不眠症に対するDTx有効性に対するセラピストの指針の影響を決定する.
主な方法
- 2024年10月まで7つの主要な科学データベースで 体系的な検索が行われました
- 118,970人の参加者を対象とした28件の体系的レビューとメタ解析が含まれています.
- 不眠症の重症度指数 (ISI) と総睡眠時間 (TST) は,主および二次的な結果指標でした.
主要な成果
- デジタル療法では,不眠症の重度の有意な低下が示されました (SMD = - 0. 42, p < 0. 01).
- 改善はフォローアップ (SMD = -0. 69, p < 0. 01) とセラピストの指導 (SMD = -1. 05, p < 0. 01) でより顕著でした.
- 介入後とフォローアップの間で,総睡眠時間 (TST) の有意な差異は観察されなかった.
結論
- 不眠症の治療にはデジタル療法が 推奨されている証拠が十分あります
- セラピストによるデジタルセラピーは 不眠症の症状を 改善する上で優れた成果を示しています
- デジタルセラピーは 不眠症の治療に 有効で有効な手段です
関連する概念動画
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

